- Home
- CRDF vs JHI Comparison
CRDF vs JHI Comparison
Compare CRDF & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRDF | JHI |
|---|---|---|
| Founded | 1999 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.1M | 123.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRDF | JHI |
|---|---|---|
| Price | $2.16 | $14.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.63 | N/A |
| AVG Volume (30 Days) | ★ 730.8K | 29.5K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | ★ $501,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.47 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.90 | $11.63 |
| 52 Week High | $5.64 | $13.40 |
Technical Indicators
Market Signals| Indicator | CRDF | JHI |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | 68.03 |
| Support Level | $2.03 | $13.54 |
| Resistance Level | $2.37 | $14.05 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 55.32 | 94.28 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.